Clinical Trial Update: Biological Bone Markers and Hydrolyzed Collagen Supplement in Menopausal Healthy Women [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of a hydrolyzed collagen supplement on biological bone markers in menopausal healthy women; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Hydrolyzed collagen supplement (collagen hydrolysate)

Snippet

Sponsor: Nealth Sarl | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED